First large-scale clinical trials in psilocybin therapy for treatment-resistant depression launches

Volunteer for Clinical Trials

Have you ever thought about taking part in a Medical Trial? By registering your details with MedTrials.co.uk, we are able to send your details directly to companies who are looking for volunteers to take part in their medical research studies.

Information about you is kept on a register that CROs, Pharmaceutical companies and Clinical Investigators can access to contact you regarding individual studies.

First large-scale clinical trials in psilocybin therapy for treatment-resistant depression launches

COMPASS Pathways, a healthcare company dedicated to accelerating patient access to evidence-based innovation in mental health, announced that it is partnering with Worldwide Clinical Trials to conduct a major program of late-stage clinical trials for psilocybin therapy for treatment-resistant depression. Depression is the leading cause of ill-health and disability worldwide, and one of the fastest growing health […]

The post First large-scale clinical trials in psilocybin therapy for treatment-resistant depression launches appeared first on CenterWatch News Online.

News

A new clinical trial suggests that taking aspirin and an omega-3 fatty acid can decrease the number of precancerous growths in the colon. Powered by WPeMatico

Millions of people live with peanut allergy, for which there is currently no available treatment. Thanks to a new study, though, this may soon change. Powered by WPeMatico

A new clinical trial finds that a novel drug can boost the strength of radiation therapy in the fight against cancer with ‘minimal side effects.’ Powered by WPeMatico

Two large new clinical trials have examined the benefits of vitamin D and fish oil supplements for staving off heart disease and cancer. Powered by WPeMatico

An existing drug that people use to treat seizures can significantly reduce symptoms of major depressive disorder in a small number of participants. Powered by WPeMatico

A new antibiotic able to kill drug-resistant bacteria proves to be safe and effective in a phase II clinical trial, offering fresh hope in a global crisis. Powered by WPeMatico

Clinical Trials and Medical Trials recruitment in the UK

Volunteer for Clinical Trials

First large-scale clinical trials in psilocybin therapy for treatment-resistant depression launches

News

How aspirin and omega-3 may reduce cancer risk

‘Breakthrough’ treatment for peanut allergy awaits FDA check

New cancer drug safely boosts radiation therapy

Vitamin D, fish oil supplements of little benefit to heart health

Major depression: Existing drug reduces symptoms by 45 percent

New drug kills antibiotic-resistant bacteria in clinical trial